Bluewater’s American odyssey

A new licensing agreement will see Bluewater Bio’s proprietary technology rolled out across the US. Its new partner stopped short of an equity stake.

Wastewater treatment specialist Bluewater Bio used the WEFTEC event in October to publicly unveil a licencing agreement with Suez Environnement subsidiary Infilco Degremont, which will enable its hybrid activated sludge technology to be rolled out across North America.

 
“This is without question one of the most important deals that we’ve done to date,” Bluewater Bio CEO Daniel Ishag told ...

Subscription required

To read this full article you must be subscribed to Global Water Intelligence.
Subscribe Now, Sign up for a Free Trial or Log In